Literature DB >> 26125709

Meta-analysis of differentially expressed genes in ankylosing spondylitis.

Y H Lee1, G G Song2.   

Abstract

The purpose of this study was to identify differentially expressed (DE) genes and biological processes associated with changes in gene expression in ankylosing spondylitis (AS). We performed a meta-analysis using the integrative meta-analysis of expression data program on publicly available microarray AS Gene Expression Omnibus (GEO) datasets. We performed Gene Ontology (GO) enrichment analyses and pathway analysis using the Kyoto Encyclopedia of Genes and Genomes. Four GEO datasets, including 31 patients with AS and 39 controls, were available for the meta-analysis. We identified 65 genes across the studies that were consistently DE in patients with AS vs controls (23 upregulated and 42 downregulated). The upregulated gene with the largest effect size (ES; -1.2628, P = 0.020951) was integral membrane protein 2A (ITM2A), which is expressed by CD4+ T cells and plays a role in activation of T cells. The downregulated gene with the largest ES (1.2299, P = 0.040075) was mitochondrial ribosomal protein S11 (MRPS11). The most significant GO enrichment was in the respiratory electron transport chain category (P = 1.67 x 10-9). Therefore, our meta-analysis identified genes that were consistently DE as well as biological pathways associated with gene expression changes in AS.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26125709     DOI: 10.4238/2015.May.18.6

Source DB:  PubMed          Journal:  Genet Mol Res        ISSN: 1676-5680


  9 in total

Review 1.  Expression and Metabolomic Profiling in Axial Spondyloarthritis.

Authors:  Darren D O'Rielly; Guangju Zhai; Proton Rahman
Journal:  Curr Rheumatol Rep       Date:  2018-06-27       Impact factor: 4.592

2.  Transcriptomic characterization of differential gene expression in oral squamous cell carcinoma: a meta-analysis of publicly available microarray data sets.

Authors:  Yang Sun; Zhijian Sang; Qian Jiang; Xiaojun Ding; Youcheng Yu
Journal:  Tumour Biol       Date:  2016-10-04

Review 3.  The Diseased Mitoribosome.

Authors:  Alberto Ferrari; Samuel Del'Olio; Antoni Barrientos
Journal:  FEBS Lett       Date:  2020-12-22       Impact factor: 4.124

Review 4.  Role of GTPases in Driving Mitoribosome Assembly.

Authors:  Priyanka Maiti; Elena Lavdovskaia; Antoni Barrientos; Ricarda Richter-Dennerlein
Journal:  Trends Cell Biol       Date:  2021-01-05       Impact factor: 20.808

5.  STAT3 and SPI1, may lead to the immune system dysregulation and heterotopic ossification in ankylosing spondylitis.

Authors:  Tuo Liang; Jiarui Chen; GuoYong Xu; Zide Zhang; Jiang Xue; Haopeng Zeng; Jie Jiang; Tianyou Chen; Zhaojie Qin; Hao Li; Zhen Ye; Yunfeng Nie; Xinli Zhan; Chong Liu
Journal:  BMC Immunol       Date:  2022-01-22       Impact factor: 3.615

6.  Assay of Peripheral Regulatory Vδ1 T Cells in Ankylosing Spondylitis and its Significance.

Authors:  Hongliang Wang; Na Sun; Ka Li; Jiguang Tian; Jianmin Li
Journal:  Med Sci Monit       Date:  2016-09-06

7.  Oxidative stress-mediated mitochondrial dysfunction facilitates mesenchymal stem cell senescence in ankylosing spondylitis.

Authors:  Guiwen Ye; Zhongyu Xie; Huiqiong Zeng; Peng Wang; Jinteng Li; Guan Zheng; Shan Wang; Qian Cao; Ming Li; Wenjie Liu; Shuizhong Cen; Zhaofeng Li; Yanfeng Wu; Zhizhong Ye; Huiyong Shen
Journal:  Cell Death Dis       Date:  2020-09-17       Impact factor: 8.469

8.  Distinct gene expression characteristics in epithelial cell-Porphyromonas gingivalis interactions by integrating transcriptome analyses.

Authors:  Dongmei Zhang; Jingya Hou; Yun Wu; Yanqing Liu; Rong Li; Tong Xu; Junchao Liu; Yaping Pan
Journal:  Int J Med Sci       Date:  2019-09-07       Impact factor: 3.738

9.  Co-expression Network Analysis Reveals Key Genes Related to Ankylosing spondylitis Arthritis Disease: Computational and Experimental Validation.

Authors:  Leila Najafzadeh; Mahdi Mahmoudi; Mostafa Ebadi; Marzieh Dehghan Shasaltaneh
Journal:  Iran J Biotechnol       Date:  2021-01-01       Impact factor: 1.671

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.